FDA's legal charter is to protect the U.S. from ineffective and unsafe drugs. Leronlimab has shown it is ineffective at treating CoV, like numerous other drugs that haven't been approved. Post-hoc analysis of failed trials for data dredged, subgroup analysis is not approvable. Read the FDA Statement.
FDA doesn't need to cover their butts. The FDA Statement was to reprimand Cytodyn for misrepresenting and manipulating CoV clinical trial data. That is illegal, thus the SEC and DOJ investigations. FDA is certainly not losing any sleep over Cytodyn -- who can't even file a "complete" BLA because the CEO is using it as cover to hype the stock price so he could sell $15 million worth of his stocks. When the NP email to Amarex directing them to file whatever they have even if they are short -- the evidence is pretty clear the intent.